Patent · US Active

Antibodies to Feline McDonough Sarcoma (FMS)-like tyrosine kinase 3 receptor ligand (FLT3L) and uses thereof for treating autoimmune and inflammatory diseases

US11512127B2 · kind B2 · utility

1Cited by
57References
21Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 13, 2019
Grant dateNov 29, 2022
Priority date—
Expiry dateOct 24, 2039

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/76
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided herein are anti-FLT3L antibodies and methods of using the antibodies to treat autoimmune and other inflammatory diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.